Figure 4.
Therapeutic options to inhibit YAP/TAZ activity. HMGCR, β-hydroxy-β-methylglutaryl coenzyme A reductase; RHO, RAS homolog family member; SRC, non-receptor protein tyrosine kinase SRC; TNKS, tankyrase.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.